A positive association between the human tissue kallikerin gene A2233C polymorphism and blood pressure response to benazepril

References

• Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371:1513–8.
   PubMed Web of Science ®Google Scholar
• Wijaya I, Siregar P. Hypertensive crises in the adolescent: Evaluation of suspected renovascular hypertension. Acta Med Indones 2013;45:49–54.
   PubMedGoogle Scholar
• Xi B, Cheng H, Shen Y, et al. Physical activity modifies the associations between genetic variants and hypertension in the Chinese children. Atherosclerosis 2012;225:376–80.
   PubMed Web of Science ®Google Scholar
• Tanira MO, Al Balushi KA. Genetic variations related to hypertension: A review. J Hum Hypertens 2005;19:7–19.
   PubMed Web of Science ®Google Scholar
• Xi B, Chen M, Chandak GR, et al. STK39 Polymorphism is associated with essential hypertension: A systematic review and meta-analysis. PLoS One 2013;8:e59584.
   PubMed Web of Science ®Google Scholar
• Fan FF, Huo Y, Wang X, et al. Effect of enalapril on plasma homocysteine levels in patients with essential hypertension. J Zhejiang Univ Sci B 2010;11:583–91.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hong XM, Xing HX, et al. E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients. Chin Med J (Engl) 2009;122:2461–5.
   PubMed Web of Science ®Google Scholar
• Xiong W, Chao J, Chao L. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 1995;25:715–9.
   PubMed Web of Science ®Google Scholar
• Puddu P, Puddu GM, Cravero E, et al. The genetic basis of essential hypertension. Acta Cardiol 2007; 62:281–93.
   PubMed Web of Science ®Google Scholar
• Yu H, Song Q, Freedman BI, et al. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney Int 2002;61:1030–9.
   PubMed Web of Science ®Google Scholar
• Clements JA. The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation. Endocr Rev 1989;10:393–419.
   PubMed Web of Science ®Google Scholar
• Murray SR, Chao J, Lin FK, et al. Kallikrein multigene families and the regulation of their expression. J Cardiovasc Pharmacol 1990;15 Suppl 6:S7–16.
   PubMed Web of Science ®Google Scholar
• Pravenec M, Kren V, Kunes J, et al. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991;17:242–6.
   PubMed Web of Science ®Google Scholar
• Woodley-Miller C, Chao J, Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens 1989;7:865–71.
   PubMed Web of Science ®Google Scholar
• Wang J, Xiong W, Yang Z, et al. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994;23:236–43.
   PubMed Web of Science ®Google Scholar
• Hua H, Zhou S, Liu Y, et al. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. J Hum Hypertens 2005;19:715–21.
   PubMed Web of Science ®Google Scholar
• Rossi GP, Taddei S, Ghiadoni L, et al. Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects. J Hypertens 2006;24:1955–63.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang L, Lu X, et al. A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: A tagging SNP-based association study in a Chinese Han population. J Hypertens 2007;25:1821–7.
   PubMed Web of Science ®Google Scholar
• Berge KE, Bakken A, Bohn M, et al. Analyses of mutations in the human renal kallikrein (hKLK1) gene and their possible relevance to blood pressure regulation and risk of myocardial infarction. Clin Genet 1997;52:86–95.
   PubMed Web of Science ®Google Scholar
• Balfour JA, Goa KL. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure. Drugs 1991;42:511–39.
   Google Scholar
• Evans BA, Yun ZX, Close JA, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry 1988;27:3124–9.
   PubMed Web of Science ®Google Scholar
• Huang G, Ying J, Hong ZY, et al. Study on association between interleukin-1β gene polymorphism and benazepril response. J Univer Sci Technol China 2003;33:491–9.
   Google Scholar
• Massie BM. Demographic considerations in the selection of antihypertensive therapy. Am J Cardiol 1987;60:121–6.
   Web of Science ®Google Scholar
• Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1–80.
   PubMed Web of Science ®Google Scholar
• Mahabeer R, Bhoola KD. Kallikrein and kinin receptor genes. Pharmacol Ther 2000;88:77–89.
   PubMed Web of Science ®Google Scholar
• Meneton P, Bloch-Faure M, Hagege AA, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A 2001;98:2634–9.
   PubMed Web of Science ®Google Scholar
• Reiser G, Hamprecht B. Bradykinin causes a transient rise of intracellular Ca2+-activity in cultured neural cells. Pflugers Arch 1985;405:260–4.
   PubMed Web of Science ®Google Scholar
• Danser AH, Schunkert H. Renin-angiotensin system gene polymorphisms: Potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 2000;410:303–16.
   PubMed Web of Science ®Google Scholar
• Kajiyama N, Saito Y, Miyamoto Y, et al. Lack of association between T-786-C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 2000;23:561–5.
   PubMed Web of Science ®Google Scholar
• Rutherford S, Johnson MP, Curtain RP, et al. Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension. Hum Gene 2001;109:408–15.
   PubMed Web of Science ®Google Scholar
• Tiret L, Poirier O, Hallet V, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999;33:1169–74.
   PubMed Web of Science ®Google Scholar
• Jin JJ, Nakura J, Wu Z, et al. Association of endothelin-1 gene variant with hypertension. Hypertension 2003;4:163–7.
   Web of Science ®Google Scholar
• Asai T, Ohkubo T, Katsuya T, et al. Endothelin-1 gene variant associated with blood pressure in obese Japanese subjects: The Ohasama Study. Hypertension 2001;38:1321–4.
   PubMed Web of Science ®Google Scholar